ALSO IN THIS MONTH'S ISSUE

  • CMS Opens Path To Reform Of Part D
    CMS Opens Path To Reform Of Part D

    Pressure had been building for more than a year for something to be done about drug prices, and specifically inflated list prices to the patient at the pharmacy counter that do not reflect the substantial rebates manufacturers are providing. Where was all the money going? How could the list price and patient copays for drugs keep rising when the net prices — accounting for manufacturer rebates — stayed level?

  • Creating A Contingency Plan: Top 4 Pharma Concerns As Brexit Approaches
    Creating A Contingency Plan: Top 4 Pharma Concerns As Brexit Approaches

    March 30, 2019 — Brexit D-Day — isn’t as far in the distant future as some might hope. For U.S. pharma companies with headquarters or CROs in the U.K., much needs to be decided, planned, and executed before that time to ensure a smooth transition.

  • A Celgene Exec's Unexpected Trip To Washington, D.C.
    A Celgene Exec's Unexpected Trip To Washington, D.C.

    Recounting what an executive did while on sabbatical wouldn’t normally fit into our editorial model. That is, unless that executive is Richard Bagger, J.D., EVP of corporate affairs and market access for Celgene.

  • Breaking The Mold — A New Perspective On Alzheimer’s
    Breaking The Mold — A New Perspective On Alzheimer’s

    Casey Lynch has long had the gut feeling there was more to the cause of Alzheimer’s than beta amyloid and tau proteins. Turns out, she was right.

  • 5 Leadership Questions For Camilla Harder Hartvig
    5 Leadership Questions For Camilla Harder Hartvig

    Camilla Harder Hartvig is SVP of Canada and EMEA for Alexion Pharmaceuticals. Previously she was president, Europe and emerging markets, at Glenmark Pharmaceuticals and also worked for companies such as Allergan, AstraZeneca, and Novartis in various managerial positions.

More from this month's issue

BEYOND THE PRINTED PAGE

More beyond the printed page articles

WEB-EXCLUSIVE EDITORIAL

More web-exclusive editorial

 EVENTS

CAPA and Root Cause Analysis Essentials Post ICH GCP E6 (R2) Addendum January 22, 2018
11am-12:30pm EST, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Sterility Failure Investigations – A Step-by-Step Process for Success January 24, 2018
1pm-2:30pm EST, Online Training)
Price:  $299 - Includes Bonus Handouts!
The New Medical Device Reporting (MDR) Guidance – An Easily Digestible Compliance Breakdown January 25, 2018
1pm-2:30pm EST, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Cell Therapy: Process Design Considerations To Support Commercialization February 1, 2018
1pm-2:30pm EST, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
ICH E6 Addendum R2 Team Training and Action Planning February 5, 2018
11am-12:30pm EST, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
More events....

JANUARY 2018 DIGITAL EDITION

2017 CMO & CRO AWARDS EDITIONS

   

@LIFESCILEADER1